Home > News > Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
August 24th, 2004
Biophan Technologies Files 8-K Providing NASA Conference Call Transcript
Biophan Technologies, Inc. announced today that it has filed an 8-K with the Securities and Exchange Commission providing a transcript of the Company's investor conference call on Thursday, August 19, during which Biophan CEO Michael Weiner detailed to investors and other interested parties information on the Biophan / NASA's Ames Research Center agreement calling for characterization and joint development of high-density, nano-engineered thermoelectric materials for use with implantable medical devices.
Renishaw receives Queen's Award for spectroscopy developments November 25th, 2014
JPK reports on the use of AFM and the CellHesion module to study plant cells at the University of Queensland November 25th, 2014
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research yields material made of single-atom layers that snap together like Legos November 25th, 2014